Morten Herholdt
Stock Analyst at HSBC
(1.65)
# 3,191
Out of 4,752 analysts
17
Total ratings
50%
Success rate
-5.45%
Average return
Main Sectors:
Stocks Rated by Morten Herholdt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Upgrades: Buy | n/a | $246.31 | - | 2 | Oct 30, 2024 | |
| ZTS Zoetis | Maintains: Buy | $230 → $225 | $171.39 | +31.28% | 2 | May 8, 2024 | |
| BIIB Biogen | Maintains: Buy | $339 → $342 | $143.28 | +138.69% | 2 | May 3, 2024 | |
| GILD Gilead Sciences | Upgrades: Hold | $69 | $98.27 | -29.79% | 2 | Apr 24, 2024 | |
| JNJ Johnson & Johnson | Upgrades: Buy | $169 → $170 | $153.48 | +10.76% | 2 | Apr 18, 2024 | |
| BLUE bluebird bio | Maintains: Reduce | $46 → $20 | $7.18 | +184.12% | 2 | Mar 5, 2024 | |
| UNH UnitedHealth Group | Initiates: Hold | $540 | $546.19 | -1.13% | 1 | Sep 6, 2023 | |
| LIVN LivaNova | Initiates: Hold | $52 | $48.68 | +6.83% | 1 | Sep 6, 2023 | |
| IQV IQVIA Holdings | Initiates: Buy | $260 | $200.88 | +29.43% | 1 | Sep 6, 2023 | |
| AMGN Amgen | Initiates: Buy | $320 | $289.06 | +10.70% | 1 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.22 | +850.82% | 1 | Sep 6, 2023 |
Labcorp Holdings
Oct 30, 2024
Upgrades: Buy
Price Target: n/a
Current: $246.31
Upside: -
Zoetis
May 8, 2024
Maintains: Buy
Price Target: $230 → $225
Current: $171.39
Upside: +31.28%
Biogen
May 3, 2024
Maintains: Buy
Price Target: $339 → $342
Current: $143.28
Upside: +138.69%
Gilead Sciences
Apr 24, 2024
Upgrades: Hold
Price Target: $69
Current: $98.27
Upside: -29.79%
Johnson & Johnson
Apr 18, 2024
Upgrades: Buy
Price Target: $169 → $170
Current: $153.48
Upside: +10.76%
bluebird bio
Mar 5, 2024
Maintains: Reduce
Price Target: $46 → $20
Current: $7.18
Upside: +184.12%
UnitedHealth Group
Sep 6, 2023
Initiates: Hold
Price Target: $540
Current: $546.19
Upside: -1.13%
LivaNova
Sep 6, 2023
Initiates: Hold
Price Target: $52
Current: $48.68
Upside: +6.83%
IQVIA Holdings
Sep 6, 2023
Initiates: Buy
Price Target: $260
Current: $200.88
Upside: +29.43%
Amgen
Sep 6, 2023
Initiates: Buy
Price Target: $320
Current: $289.06
Upside: +10.70%
Sep 6, 2023
Initiates: Buy
Price Target: $12
Current: $1.22
Upside: +850.82%